Literature DB >> 2660792

The molecular basis of retinoic acid induced night blindness.

W C Law1, R R Rando.   

Abstract

Drugs which affect the processing of vitamin A in the retina or pigment epithelium can cause ocular toxicity. It is shown here that the retinoic acids, which are used in the treatment of skin disorders and which cause night blindness, inhibit the ocular retinol dehydrogenases in an in vitro system. This is shown to lead to a decrease in the formation of the visual chromophore 11-cis-retinal, thus explaining why night blindness might occur.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660792     DOI: 10.1016/0006-291x(89)92674-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

Review 2.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

3.  Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina.

Authors:  Marcin Golczak; Akiko Maeda; Grzegorz Bereta; Tadao Maeda; Philip D Kiser; Silke Hunzelmann; Johannes von Lintig; William S Blaner; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

4.  Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Steven Nusinowitz; Xinran Liu; Paul A Sieving; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

Review 5.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

6.  Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation.

Authors:  Roxana A Radu; Quan Yuan; Jane Hu; Jennifer H Peng; Marcia Lloyd; Steven Nusinowitz; Dean Bok; Gabriel H Travis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

Review 7.  Adverse reactions to oral retinoids. An update.

Authors:  C M Mills; R Marks
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

8.  Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Aarti Bagla; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

Review 9.  An analysis of retinal gene therapy clinical trials.

Authors:  Robert E MacLaren
Journal:  Curr Opin Mol Ther       Date:  2009-10

10.  The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration.

Authors:  Deviprasad R Gollapalli; Robert R Rando
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.